PCAS : confirms its PME SME eligibility

4a2e273c-cbda-4163-aa0d-9674144f5e89.pdf Press Release PCAS CONFIRMS ITS PEA-SME ELIGIBILITY FOR 2016/2017 Longjumeau, 21st June 2016 PCAS (Euronext Paris : PCA - FR0000053514), development and production specialist of complex molecules for life science and innovative technologies, confirms for the next 12 months its eligibility for the French PEA-SMEs tax-efficient investment regime, as defined in article L221-32-2 of the French Monetary and Financial code, and as amended by Law n° 2015-1786 of the 29th december 2015 - art. 27 (V).

Consequently, PCAS shares continue to be eligible for incorporation into the PEA-SMEs accounts, which benefit from the same tax advantages as the traditional French Share Savings Plan (PEA).

About PCAS

PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers of a growing range of proprietary products and solutions in leading-edge segments and also includes two very high-potential subsidiaries: Protéus in biotechnology and Enersens in high-performance insulation. PCAS generated net sales of €179.1 million in 2015 and employs close to 900 people in six countries.

To find out more about PCAS, visit: www.pcas.com

Contacts : PCAS	NewCap
Vincent Touraille / Eric Moissenot PCAS	Emmanuel Huynh / Louis-Victor Delouvrier Financial communication and Investor Relations
+33 1 69 79 61 32 www.pcas.com	+33 1 44 71 98 53 pcas@newcap.eu

Page 1